NRG Oncology/RTOG 1112

NRG Oncology/RTOG 1112 - Randomized Phase III Study of Sorafenib versus Stereotactic Body Radiation Therapy followed by Sorafenib in Hepatocellular Carcinoma

This app is intended to be a quick reference resource for physicians. It does NOT replace the full-length protocol. All activities related to the trial must adhere to the official protocol (RTOG1112) which can be found on the CTUS website (www.ctsu.org) and the NRG website (http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=1112).